Aridis Pharmaceuticals ARDS

$ 0.31 17.91%

Quarterly report 2023-Q3
added 11-06-2023

Aridis Pharmaceuticals Balance Sheet 2011-2024 | ARDS

Annual Balance Sheet Aridis Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-3.05 M	-	-8.23 M	-20.9 M	-24.2 M	-25.1 M	-22.3 M	-	-	-	-	-
Long Term Debt	1.29 M	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	538 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	854 K	5 M	-	11.9 M	6.36 M	-	-	-	-	-
Total Current Liabilities	36.9 M	33.3 M	22.4 M	19.3 M	5.3 M	-	-	-	-	-	-	-
Total Liabilities	38.9 M	39.9 M	23.8 M	24.3 M	5.3 M	15 M	8.76 M	-	-	-	-	-
Deferred Revenue	20.2 M	20.8 M	18.7 M	14.6 M	22 K	120 K	-	-	-	-	-	-
Retained Earnings	-196 M	-165 M	-	-101 M	-71.1 M	-47.6 M	-20.2 M	-	-	-	-	-
Total Assets	14.7 M	26.8 M	15.1 M	28 M	31.6 M	26.5 M	22.5 M	-	-	-	-	-
Cash and Cash Equivalents	4.88 M	18.1 M	8.23 M	20.9 M	24.2 M	25.1 M	-	-	-	-	-	-
Book Value	-24.2 M	-13.1 M	-8.68 M	3.64 M	26.3 M	11.4 M	13.8 M	-	-	-	-	-
Total Shareholders Equity	-24.2 M	-13.1 M	-8.68 M	3.64 M	26.3 M	-62.8 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Aridis Pharmaceuticals

	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	854 K	1.29 M	1.43 M	1.56 M	1.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	18.3 M	38.9 M	47.9 M	44.6 M	44.2 M	39.9 M	30.2 M	24.9 M	26.1 M	23.8 M	23.8 M	23.8 M	23.8 M	24.3 M	24.3 M	24.3 M	24.3 M	5.3 M	5.3 M	5.3 M	5.3 M	15 M	15 M	15 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	380 K	20.2 M	20.4 M	20.7 M	21 M	20.8 M	19.6 M	19.3 M	19.3 M	18.7 M	18.7 M	18.7 M	18.7 M	14.6 M	14.6 M	14.6 M	14.6 M	22 K	22 K	22 K	22 K	120 K	120 K	120 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-190 M	-196 M	-189 M	-181 M	-173 M	-165 M	-156 M	-135 M	-130 M	-123 M	-123 M	-123 M	-123 M	-101 M	-101 M	-101 M	-101 M	-71.1 M	-71.1 M	-71.1 M	-71.1 M	-47.6 M	-47.6 M	-47.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	6.53 M	14.7 M	12.1 M	16.7 M	23.8 M	26.8 M	26.1 M	11.4 M	17.6 M	15.1 M	15.1 M	15.1 M	15.1 M	28 M	28 M	28 M	28 M	31.6 M	31.6 M	31.6 M	31.6 M	26.5 M	26.5 M	26.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	35 K	4.88 M	3.13 M	6.32 M	12.5 M	18.1 M	18.7 M	4.09 M	10.5 M	8.23 M	8.23 M	8.23 M	8.23 M	20.9 M	20.9 M	20.9 M	20.9 M	24.2 M	24.2 M	24.2 M	24.2 M	25.1 M	25.1 M	25.1 M	-	22.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-11.8 M	-24.2 M	-35.8 M	-27.9 M	-20.4 M	-13.1 M	-4.16 M	-13.5 M	-8.56 M	-8.68 M	-8.68 M	-8.68 M	-8.68 M	3.64 M	3.64 M	3.64 M	3.64 M	26.3 M	26.3 M	26.3 M	26.3 M	11.4 M	11.4 M	11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-11.8 M	-24.2 M	-35.8 M	-27.9 M	-20.4 M	-13.1 M	-4.16 M	-13.5 M	-8.56 M	-8.68 M	-8.68 M	-8.68 M	-8.68 M	3.64 M	3.64 M	3.64 M	3.64 M	26.3 M	26.3 M	26.3 M	26.3 M	-62.8 M	-62.8 M	-62.8 M	-	-45.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency